{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:31:30Z","timestamp":1788777090548,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Malaria remains a global health concern, with\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      as predominant species in the Americas. The region has made notable strides in reducing malaria incidence, but challenges persist. Guiana Shield countries share similar malaria ecologies and vector dynamics, yet their progress toward elimination is quite different. Suriname, a low-middle income country, has pursued malaria elimination and became the first Amazonian country to receive malaria-free certification in June 2025. However, the reintroduction through imported cases from neighboring countries with higher endemicity remains a serious threat, as exemplified by the 2019 outbreak in Pelele Tepoe. The response strategy and operational measures implemented to address this\n                      <jats:italic>P. vivax<\/jats:italic>\n                      outbreak are described, along with key lessons for effective outbreak management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This descriptive study examines Suriname\u2019s most recent\n                      <jats:italic>P. vivax<\/jats:italic>\n                      outbreak, using surveillance and intervention data from November 2019 to August 2021. It outlines the rationale for employing an adaptive, multi-pronged outbreak management strategy, details implementation of approaches, tailored to evolving outbreak circumstances and evaluates the effectiveness of subsequent interventions. Factors contributing to the outbreak\u2019s prolonged duration, including COVID-19 pandemic impact are discussed, along with the resulting adaptations in the targeted responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>P. vivax<\/jats:italic>\n                      outbreak lasted 22 months, resulting in 179 infections among 153 patients. Traditional strategies with corresponding interventions were introduced at onset, including \u201c1-3-7\u201d surveillance, community education and engagement and vector control. Continuous trend monitoring guided the adoption of additional less conventional and innovative measures, including mass screen-and-treat, mass drug administration (MDA), parasite genotyping and targeted treatment. Mass screen-and-treat was less effective in reducing parasite prevalence than MDA. Directly observed treatment reached 95.1% efficacy by day 180, however, relapses appeared to fuel the outbreak. Implementation of the \u201cRadical Cure\u201d marked the end of the outbreak.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The described adaptive, integrated, six-pronged approach, combining conventional strategies with targeted accelerator methods and inclusive stakeholder engagement can effectively control outbreaks in low-endemic or near-elimination regions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0013970","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:22:25Z","timestamp":1771006945000},"page":"e0013970","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["A six-pronged approach to manage a Plasmodium vivax outbreak in a low- and middle-income country on the road to malaria elimination"],"prefix":"10.1371","volume":"20","author":[{"given":"Mergiory","family":"Labadie-Bracho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaitree K.","family":"Baldewsingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Hiwat van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2001-9994","authenticated-orcid":true,"given":"Malti R.","family":"Adhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"pntd.0013970.ref001","volume-title":"World malaria report 2024: addressing inequity in the global malaria response","author":"WHO","year":"2024"},{"key":"pntd.0013970.ref002","volume-title":"Global technical strategy for malaria 2016\u20132030, 2021 update","author":"WHO","year":"2021"},{"key":"pntd.0013970.ref003","volume-title":"Global technical strategy for malaria 2016\u20132030","author":"WHO","year":"2015"},{"key":"pntd.0013970.ref004","author":"Brazilian Ministry of Health"},{"key":"pntd.0013970.ref005","volume-title":"World malaria report 2023","author":"WHO","year":"2023"},{"key":"pntd.0013970.ref006","author":"Secretaria de Estado da Sa\u00fade de Roraima","year":"2025"},{"key":"pntd.0013970.ref007","volume-title":"World malaria report 2025: addressing the threat of antimalarial drug resistance","author":"WHO","year":"2025"},{"key":"pntd.0013970.ref008","volume-title":"World malaria report 2005","author":"WHO","year":"2005"},{"key":"pntd.0013970.ref009","doi-asserted-by":"crossref","first-page":"102910","DOI":"10.1016\/j.tmaid.2025.102910","article-title":"Plasmodium falciparum malaria in Suriname: how targeted interventions in marginalized populations led to elimination","author":"H Hiwat-Van Laar","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"pntd.0013970.ref010","author":"Ministry of Health","year":"2025"},{"key":"pntd.0013970.ref011","volume-title":"Annual Malaria Report 2018","author":"Ministry of Health Suriname","year":"2018"},{"key":"pntd.0013970.ref012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1756-3305-4-177","article-title":"Ecology of Anopheles darlingi Root with respect to vector importance: a review","volume":"4","author":"H Hiwat","year":"2011","journal-title":"Parasit Vectors"},{"key":"pntd.0013970.ref013","volume-title":"Support for sustainable development of the interior project","author":"Suriname International Partners (SIP - Consortium)","year":"2010"},{"key":"pntd.0013970.ref014","author":"Ministry of Health Suriname","year":"2023"},{"issue":"11","key":"pntd.0013970.ref015","article-title":"Advocating for PCR-RFLP as molecular tool within malaria programs in low endemic areas and low resource settings","volume":"17","author":"MY Labadie-Bracho","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0013970.ref016","article-title":"Communicating and monitoring surveillance and response activities for malaria elimination: China\u2019s \u201c1-3-7\u201d strategy","volume":"11","author":"J Cao","year":"2014","journal-title":"PLoS Med"},{"issue":"4","key":"pntd.0013970.ref017","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.1999.61.518","article-title":"Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity","volume":"61","author":"MC Bruce","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013970.ref018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2875-4-20","article-title":"Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1","volume":"4","author":"M Imwong","year":"2005","journal-title":"Malar J"},{"key":"pntd.0013970.ref019","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1475-2875-10-90","article-title":"Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival","volume":"10","author":"L Hulden","year":"2011","journal-title":"Malar J"},{"key":"pntd.0013970.ref020","volume-title":"WHO Guidelines for malaria","year":"2021"},{"issue":"2","key":"pntd.0013970.ref021","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081982","article-title":"Community engagement approaches for malaria prevention, control and elimination: a scoping review","volume":"14","author":"KR Awasthi","year":"2024","journal-title":"BMJ Open"},{"issue":"10","key":"pntd.0013970.ref022","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-3156.2003.01115.x","article-title":"Rapid diagnostic testing for malaria","volume":"8","author":"CK Murray","year":"2003","journal-title":"Trop Med Int Health"},{"issue":"1","key":"pntd.0013970.ref023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4269\/ajtmh.21-0643","article-title":"Ten years of universal testing: how the rapid diagnostic test became a game changer for malaria case management and improved disease reporting","volume":"106","author":"M Aidoo","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0013970.ref024","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12916-022-02285-5","article-title":"Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment","volume":"20","author":"T Obadia","year":"2022","journal-title":"BMC Med"},{"issue":"5","key":"pntd.0013970.ref025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1473-3099(22)00697-1","article-title":"Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis","volume":"23","author":"V Wasakul","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0013970.ref026","first-page":"9","article-title":"Reconstruction of Plasmodium vivax outbreaks in a low malaria endemic setting utilizing conventional restriction fragment length polymorphism","volume":"12","author":"MY Labadie-Bracho","year":"2021","journal-title":"Int J Mol Epidemiol Genet"},{"key":"pntd.0013970.ref027","unstructured":"WHO. COVID-19 continues to disrupt essential health services in 90% of countries, News release. 2021."},{"issue":"1","key":"pntd.0013970.ref028","first-page":"30","article-title":"The impact of COVID-19 on communicable and non-communicable diseases in Africa: a narrative review","volume":"30","author":"B Formenti","year":"2022","journal-title":"Infez Med"},{"issue":"10","key":"pntd.0013970.ref029","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1473-3099(20)30313-3","article-title":"Hydroxychloroquine prophylaxis for COVID-19 contacts in India","volume":"20","author":"S Rathi","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pntd.0013970.ref030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3201\/eid0602.000202","article-title":"Malaria on the move: human population movement and malaria transmission","volume":"6","author":"P Martens","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"pntd.0013970.ref031","doi-asserted-by":"crossref","DOI":"10.1163\/9789004280120_002","article-title":"Looking at language, identity, and mobility in Suriname.","volume-title":"In and out of Suriname","author":"E Carlin","year":"2015"},{"issue":"5","key":"pntd.0013970.ref032","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/clinids\/23.5.1171","article-title":"Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America","volume":"23","author":"EJ Phillips","year":"1996","journal-title":"Clin Infect Dis"},{"key":"pntd.0013970.ref033","unstructured":"Alecrim MGC. Estudo cl\u00ednico, resist\u00eancia e polimorfi smo parasit\u00e1rio na mal\u00e1ria pelo Plasmodium vivax, Manaus \u2013 AM. Bras\u00edlia: UNB, 2000 [PhD Thesis]. Faculdade de Medicina, N\u00facleo de Medicina Tropical, Universidade de Bras\u00edlia; 2000. Available from: https:\/\/pesquisa.bvsalud.org\/portal\/resource\/pt\/lil-286675"},{"key":"pntd.0013970.ref034","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/1475-2875-9-308","article-title":"Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border","volume":"9","author":"R Takeuchi","year":"2010","journal-title":"Malar J"},{"issue":"3","key":"pntd.0013970.ref035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)00041-5","article-title":"Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment","volume":"98","author":"T Leslie","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"pntd.0013970.ref036","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1473-3099(23)00430-9","article-title":"Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis","volume":"24","author":"RJ Commons","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"pntd.0013970.ref037","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1301936","article-title":"Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria","volume":"369","author":"JW Bennett","year":"2013","journal-title":"N Engl J Med"},{"issue":"47","key":"pntd.0013970.ref038","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.47.20322-en","article-title":"Malaria in Greece, 1975 to 2010","volume":"17","author":"A Vakali","year":"2012","journal-title":"Euro Surveill"},{"issue":"3","key":"pntd.0013970.ref039","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1710775","article-title":"Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria","volume":"380","author":"MVG Lacerda","year":"2019","journal-title":"N Engl J Med"},{"key":"pntd.0013970.ref040","volume-title":"A framework for malaria elimination","author":"WHO","year":"2017"},{"key":"pntd.0013970.ref041","author":"CDC Health Update","year":"2023"},{"issue":"1","key":"pntd.0013970.ref042","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41598-022-05205-y","article-title":"Cross-border malaria in the triple border region between Brazil, Venezuela and Guyana","volume":"12","author":"R Abdallah","year":"2022","journal-title":"Sci Rep"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:22:31Z","timestamp":1771006951000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013970"}},"subtitle":[],"editor":[{"given":"Abhay R","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013970","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}